Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease

Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced disease; patient who received Namodenoson as ...

Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome

Surgical Treatment for a Rare Genetic Disorder that Causes Recurrent Basal Cell Carcinomas Beginning in ChildhoodPHILADELPHIA, June 15, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ...
Pharmabiz

US FDA approves Curis' Erivedge capsule to treat advanced basal cell carcinoma

US FDA approves Curis' Erivedge capsule to treat advanced basal cell carcinoma: Lexington, Massachusetts Wednesday, February 1, 2012, 16:00 Hrs [IST] The US Food and Drug Administ ...

Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome

Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.
Frontiers

Signal-Regulated Transcriptional and Epigenetic Reprogramming in Cancer

Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...

Neural pathways reveal a push-pull system for coordinating goal-directed behavior in mice

Most of the tasks that humans complete daily entail carefully coordinating movements and tracking progress made toward a ...
eLife

Desert Hedgehog mediates stem Leydig cell differentiation through Ptch2/Gli1/Sf1 signaling axis

Desert Hedgehog signaling promotes stem Leydig cell differentiation through a Ptch2-Gli1-Sf1 regulatory axis in Nile tilapia.